Log in

Relevant bibliographies by topics / Virus diseases – Chemotherapy / Journal articles

To see the other types of publications on this topic, follow the link: Virus diseases – Chemotherapy.

Journal articles on the topic 'Virus diseases – Chemotherapy'

Author: Grafiati

Published: 25 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Virus diseases – Chemotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq." Journal of Communicable Diseases 55, no. 04 (2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 5 (1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.

Full text

Abstract:

This paper, which is published in two parts, reviews the literature pertaining to antiviral chemotherapy of viruses of veterinary importance. While early reports in the 1970s referred to the chemotherapy of a number of different RNA and DNA viruses, there was considerable focus in the 1980s, initially on herpesviruses and latterly on retroviruses, particularly in cats. Details are given of the successful treatments of FeLV and FIV, which have been used as animal models for HIV therapy. The high costs of developing and registering a new chemical entity, especially for food species, in which ext

APA, Harvard, Vancouver, ISO, and other styles

3

Snoeck, R., G. Andrei, and E. De Clercq. "Chemotherapy of varicella zoster virus infections." International Journal of Antimicrobial Agents 4, no. 3 (1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Polsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus." Clinical Infectious Diseases 11, Supplement_7 (1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Han, Seung Beom, Hye Jo Shin, Eui Soo Lee, et al. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.

Full text

Abstract:

Background: Vaccination for hepatitis B virus (HBV) after chemotherapy among pediatric patients with acute leukemia is still a debated issue. We investigated HBV immunity before and after chemotherapy and assessed immune response to re-vaccination after chemotherapy. Methods: We retrospectively analyzed data of children and adolescents aged <19 years requested for vaccination after chemotherapy for acute leukemia to evaluate hepatitis B surface antibody (HBsAb) status before and after chemotherapy and to identify factors related to HBsAb positivity after chemotherapy. Results: O

APA, Harvard, Vancouver, ISO, and other styles

6

Rice, W. G., and J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy." Reviews in Medical Virology 6, no. 4 (1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Wainberg, Mark A., Andre Dascal, and Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases." Canadian Journal of Infectious Diseases 2, no. 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.

Full text

Abstract:

The replication cycle of human immunodeficiency virus type 1 (HIV-1) and other retroviruses consists of four stages: attachment of the virus to specific receptors on the cell surface; uncoating of the viral nucleic acid and conversion to DNA; production of viral RNA and proteins; and assembly and liberation of progeny virus from the cell. Each of these steps represents a potential target for antiviral chemotherapy. Combinations of drugs which act against different steps in the viral replication cycle might be expected to have synergistic potential. Zidovudine (AZT) is the most widely used drug

APA, Harvard, Vancouver, ISO, and other styles

8

FIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy." Journal of Antimicrobial Chemotherapy 24, no. 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Benke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, et al. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment." Pathogens 12, no. 1 (2023): 129. http://dx.doi.org/10.3390/pathogens12010129.

Full text

Abstract:

Garlic (Allium sativum L.) is a clonally propagated bulbous crop and can be infected by several viruses under field conditions. A virus complex reduces garlic yield and deteriorates the quality of the produce. In the present study, we aimed to eliminate Onion yellow dwarf virus (OYDV), Garlic common latent virus (GCLV), Shallot latent virus (SLV), and Allexiviruses from the infected crop using combination of meristem culture, thermotherapy, and chemotherapy. In this study, seven different treatments, namely shoot meristem culture, thermotherapy direct culture, chemotherapy direct culture, chem

APA, Harvard, Vancouver, ISO, and other styles

10

Dorobantu, Cristina M., Christian Harak, Rahel Klein та ін. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα". Antimicrobial Agents and Chemotherapy 60, № 10 (2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.

Full text

Abstract:

ABSTRACTEncephalomyocarditis virus (EMCV), like hepatitis C virus (HCV), requires phosphatidylinositol 4-kinase IIIα (PI4KA) for genome replication. Here, we demonstrate that tyrphostin AG1478, a known epidermal growth factor receptor (EGFR) inhibitor, also inhibits PI4KA activity, bothin vitroand in cells. AG1478 impaired replication of EMCV and HCV but not that of an EMCV mutant previously shown to escape PI4KA inhibition. This work uncovers novel cellular and antiviral properties of AG1478, a compound previously regarded only as a cancer chemotherapy agent.

APA, Harvard, Vancouver, ISO, and other styles

11

Roy, Biswajit G. "Potential of small-molecule fungal metabolites in antiviral chemotherapy." Antiviral Chemistry and Chemotherapy 25, no. 2 (2017): 20–52. http://dx.doi.org/10.1177/2040206617705500.

Full text

Abstract:

Various viral diseases, such as acquired immunodeficiency syndrome, influenza, and hepatitis, have emerged as leading causes of human death worldwide. Scientific endeavor since invention of DNA-dependent RNA polymerase of pox virus in 1967 resulted in better understanding of virus replication and development of various novel therapeutic strategies. Despite considerable advancement in every facet of drug discovery process, development of commercially viable, safe, and effective drugs for these viruses still remains a big challenge. Decades of intense research yielded a handful of natural and sy

APA, Harvard, Vancouver, ISO, and other styles

12

Patel, R., and S. E. Barton. "Antiviral Chemotherapy in Genital Herpes Simplex Virus Infections." International Journal of STD & AIDS 6, no. 5 (1995): 320–28. http://dx.doi.org/10.1177/095646249500600503.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

De Clercq, Erik. "Acyclic Nucleoside Phosphonates in the Chemotherapy of DNA Virus and Retrovirus Infections." Intervirology 40, no. 5-6 (1997): 295–303. http://dx.doi.org/10.1159/000150563.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Yeo, Winnie, Joyce L. Steinberg, John S. Tam, et al. "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy." Journal of Medical Virology 59, no. 3 (1999): 263–69. http://dx.doi.org/10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Barsukova, E. N., I. V. Kim, and T. N. Сhekushkina. "IMPROVEMENT AND IN VITRO MICROPROPAGATION OF POTATO VARIETIES FOR DISEASE-FREE SEED GROWING." Far Eastern Agrarian Herald, no. 4 (2018): 20–26. https://doi.org/10.22450/1999-6837-2018-4-20-26.

Full text

Abstract:

The quality of potato seed material is one of the main factors determining its yield. Under the long-term reproduction potato accumulates diseases, mostly viral. Viral diseases cause the decrease in yield 2-3 times, worsen the quality of tubers. It is possible to solve this problem by creating virusresistant varieties, as well as by switching seed production to a virus-free base (healthy basis). Creation of the virus – free collection under the in vitro conditions is the basis for the development of potato seed production in any region of the Russian Federation. In this regard, the purpose of

APA, Harvard, Vancouver, ISO, and other styles

16

Rollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 2. Avian, Piscine, Canine, Porcine, Bovine and Equine Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 6 (1992): 311–26. http://dx.doi.org/10.1177/095632029200300601.

Full text

Abstract:

This paper, which is published in two parts, reviews the literature pertaining to antiviral chemotherapy of viruses of veterinary importance. While early reports in the 1970s referred to the chemotherapy of a number of different RNA and DNA viruses, there was considerable focus in the 1980s, initially on herpesviruses and latterly on retroviruses, and particularly in cats. Details are given of the successful treatments of FeLV and FIV, which have been used as animal models for HIV therapy. Therapy of equine, canine, bovine, porcine, avian, and fish diseases is also considered. The high costs o

APA, Harvard, Vancouver, ISO, and other styles

17

Tien Phat, Do, Pham Bich Ngoc, and Chu Hoang Ha. "Methods to manage, protect and improve plant virus resistance." Vietnam Journal of Biotechnology 19, no. 4 (2022): 607–18. http://dx.doi.org/10.15625/1811-4989/15584.

Full text

Abstract:

Viral diseases caused severe damage for plant growth and development. Penetration and spread of viruses in the host plants dramatically reduce crop yield and quality. Due to the critical damages of viral diseases to agricultural production, different approaches and methods have been developed and utilized to manage, protect and improve plant virus resistance. Of which, conventional methods such as meristem culture, thermotherapy, cryotherapy as well as chemotherapy have been widely used and conducted effective results. Moreover, cross protection and gene pyramiding approaches have performed th

APA, Harvard, Vancouver, ISO, and other styles

18

Thackray, Alana M., and Hugh J. Field. "Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy." Antimicrobial Agents and Chemotherapy 44, no. 1 (2000): 97–102. http://dx.doi.org/10.1128/aac.44.1.97-102.2000.

Full text

Abstract:

ABSTRACT Young adult mice were inoculated with herpes simplex virus type 2 (HSV-2) in the ear pinna. A relatively severe infection resulted, and 45% of the mice died by 11 days postinfection. Therapy at 1 mg/ml by means of the drinking water with either famciclovir for periods of 5 or 10 days or valaciclovir for 5, 10, 15, or 20 days decreased clinical signs and reduced mortality to 15% or less. Throughout a period of 27 days, mice were tested daily for the presence of infectious virus in the ear pinna, brain stem, and ipsilateral trigeminal ganglia. Virus was cleared from these tissues in sur

APA, Harvard, Vancouver, ISO, and other styles

19

Hirsch, M. S. "Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects." Journal of Infectious Diseases 161, no. 5 (1990): 845–57. http://dx.doi.org/10.1093/infdis/161.5.845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Dylewski, J., and L. Thibert. "Failure of Tuberculosis Chemotherapy in a Human Immunodeficiency Virus-Infected Patient." Journal of Infectious Diseases 162, no. 3 (1990): 778–79. http://dx.doi.org/10.1093/infdis/162.3.778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Henrich, Timothy J., Kristen S. Hobbs, Emily Hanhauser, et al. "Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy." Journal of Infectious Diseases 216, no. 2 (2017): 254–62. http://dx.doi.org/10.1093/infdis/jix265.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Cingarlini, Sara. "Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature." Journal of Clinical Case Studies Reviews & Reports 5, no. 9 (2023): 1–6. http://dx.doi.org/10.47363/jccsr/2023(5)258.

Full text

Abstract:

HHV-8 is known to be related to Kaposi sarcomas but can be responsible for other diseases such as Castleman’s disease (MCD) and primary effusion lymphoma (PEL). Epstein-Barr virus, on the other hand, is generally responsible for B-lineage lymphoproliferative diseases (LPD). In this case report we describe the case of a co-infection with HHV-8 and EBV with an unusual presentation. It is in fact a Kaposi sarcoma diagnosed in a heterosexual, immunocompetent and HIV-negative patient who initially presented with nodal disease only and a severe hemolytic anaemia. The same patient was also diagnosed

APA, Harvard, Vancouver, ISO, and other styles

23

Idilman, R., M. Arat, E. Soydan, et al. "Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies." Journal of Viral Hepatitis 11, no. 2 (2004): 141–47. http://dx.doi.org/10.1046/j.1365-2893.2003.00479.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Ishii, T., M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki. "Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis." Antimicrobial Agents and Chemotherapy 40, no. 1 (1996): 241–43. http://dx.doi.org/10.1128/aac.40.1.241.

Full text

Abstract:

The ribavirin concentration in hamster brains was measured by a high-performance liquid chromatography (HPLC) system and a bioassay system. When ribavirin was administered intracranially at a dosage of 10 mg/kg of body weight per day for 10 days, a dosage which results in 100% survival of hamsters infected with subacute sclerosing panencephalitis (SSPE) virus and which inhibits the replication of SSPE virus in hamster brains, the ribavirin concentration in the brains estimated by HPLC and bioassay was kept higher than 50 micrograms/g for 10 days. The effective concentration in vivo corresponds

APA, Harvard, Vancouver, ISO, and other styles

25

Потапенко, Всеволод Геннадьевич, та М. М. Антонов. "Вторичный гемофагоцитарный синдром и хроническая активная болезнь, ассоциированные с вирусом Эпштейна—Барр (обзор литературы)". Clinical Oncohematology 18, № 3 (2025): 286–92. https://doi.org/10.21320/2500-2139-2025-18-3-286-292.

Full text

Abstract:

Epstein-Barr virus (EBV) infection can cause secondary hemophagocytic syndrome and severe chronic active disease. The diseases are characterized by pathologic hyperergic reaction manifested by fever, cytopenia, and multiple organ failure. Cytostatic therapy reduces inflammatory response, allows for infection resolution, or stabilizes the patient before the next stage of treatment. This paper reviews current knowledge about diagnosis and treatment of EBV-associated diseases with the main focus on chemotherapy for EBV-associated secondary hemophagocytic syndrome and chronic active disease.

APA, Harvard, Vancouver, ISO, and other styles

26

Oketani, Makoto, Akio Ido, Hirofumi Uto, and Hirohito Tsubouchi. "Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy." Hepatology Research 42, no. 7 (2012): 627–36. http://dx.doi.org/10.1111/j.1872-034x.2012.00998.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Locasciulli, A., M. Santamaria, G. Masera, E. Schiavon, A. Alberti, and G. Realdi. "Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy." Journal of Medical Virology 15, no. 1 (1985): 29–33. http://dx.doi.org/10.1002/jmv.1890150105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Yeo, Winnie, Paul K. S. Chan, Henry L. Y. Chan, Frankie K. F. Mo, and Philip J. Johnson. "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis." Journal of Medical Virology 65, no. 3 (2001): 473–77. http://dx.doi.org/10.1002/jmv.2060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

De Clercq, Erik. "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections." International Journal of Antimicrobial Agents 7, no. 3 (1996): 193–202. http://dx.doi.org/10.1016/s0924-8579(96)00319-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Ilyushina, Natalia A., Erich Hoffmann, Rachelle Salomon, Robert G. Webster, and Elena A. Govorkova. "Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice." Antiviral Therapy 12, no. 3 (2006): 363–70. http://dx.doi.org/10.1177/135965350701200302.

Full text

Abstract:

Background The clinical management of H5N1 influenza virus infection in humans remains unclear. Combination chemotherapy with drugs that target different viral proteins might be more effective than monotherapy. Methods BALB/c mice were treated by oral gavage for 5 days with amantadine (1.5, 15 or 30 mg/kg/day) and oseltamivir (1 or 10 mg/kg/day) separately or in combination. Mice were challenged 24 h after initiation of treatment with 10 mouse 50% lethal doses of either amantadine-sensitive (having S31 in the M2 protein) or amantadine-resistant (having N31 in the M2 protein) recombinant A/Viet

APA, Harvard, Vancouver, ISO, and other styles

31

Zumla, A., and S. L. Croft. "Chemotherapy and immunity in opportunistic parasitic infections in AIDS." Parasitology 105, S1 (1992): S93—S101. http://dx.doi.org/10.1017/s0031182000075405.

Full text

Abstract:

SUMMARYParasitic diseases are endemic in parts of the tropics, but there is no convincing evidence that their prevalence or incidence is increasing due to the HIV epidemic. Available scientific data on parasitic infections in patients with the Acquired Immunodeficiency Syndrome (AIDS) suggests a predominance of Pneumocystis carinii, Toxoplasma gondii and Cryptosporidium spp. For reasons which are unclear, parasitic infections such as Plasmodium falciparum, Strongyloides stercoralis and Entamoeba histolytica, where cell-mediated immune responses are also thought to be significant, do not appear

APA, Harvard, Vancouver, ISO, and other styles

32

Sjöberg, Anita Herrström, Liya Wang, and Staffan Eriksson. "Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy." Antimicrobial Agents and Chemotherapy 45, no. 3 (2001): 739–42. http://dx.doi.org/10.1128/aac.45.3.739-742.2001.

Full text

Abstract:

ABSTRACT A highly active form of human recombinant deoxyguanosine kinase (dGK) phosphorylated purine nucleoside analogs active against cytomegalovirus, hepatitis B virus, and human immunodeficiency virus, such as penciclovir, 2′,3′-dideoxyguanosine and 3′-fluoro-2′,3′-dideoxyguanosine. The antiherpesvirus drug ganciclovir, which is also used in gene therapy, was a substrate for dGK, but with low efficiency. ATP and UTP were both good phosphate donors, with apparent Km values of 6 and 4 μM andV max values of 34 and 90 nmol of dGMP/mg of dGK/min, respectively. With a mixture of 5 mM ATP and 0.05

APA, Harvard, Vancouver, ISO, and other styles

33

Chen, Jungang, Samantha Kendrick, and Zhiqiang Qin. "Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas." Viruses 11, no. 12 (2019): 1161. http://dx.doi.org/10.3390/v11121161.

Full text

Abstract:

Viral lymphomagenesis induced by infection with oncogenic viruses, such as Kaposi’s sarcoma associated herpesvirus (KSHV), Epstein–Barr virus (EBV) and human T-cell leukemia virus (HTLV-1), represents a group of aggressive malignancies with a diverse range of pathological features. Combined chemotherapy remains the standard of care for these virus-associated lymphomas; however, frequent chemoresistance is a barrier to achieving successful long-term disease-free survival. There is increasing evidence that indicates virus-associated lymphomas display more resistance to cytotoxic chemotherapeutic

APA, Harvard, Vancouver, ISO, and other styles

34

Zon, Robin T., and Michael N. Neuss. "ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases." Journal of Oncology Practice 6, no. 4 (2010): 193–94. http://dx.doi.org/10.1200/jop.777007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Yeo, Winnie, Paul K. S. Chan, Pun Hui, et al. "Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study." Journal of Medical Virology 70, no. 4 (2003): 553–61. http://dx.doi.org/10.1002/jmv.10430.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

KOTLYAR, V. K., S. V. FEDOROVICH, and O. L. SEGET. "IMPROVEMENT OF GRAPE CUTTINGS BY THERMOTHERAPY AGAINST GLRAV-3 VIRUS." Scientific Works of North Caucasian Federal Scientific Center of Horticulture Viticulture Wine-making 37 (September 2023): 107–10. http://dx.doi.org/10.30679/2587-9847-2023-37-107-110.

Full text

Abstract:

GLRaV-3 is a systemic phloem virus, has been detected in almost all wine regions of the world and is responsible for significant economic damage. The use of healthy breeding material is crucial for the control of vine diseases caused by viruses, due to the lack of established treatment for viral diseases in the field conditions. In this study, we conducted a series of experiments on thermotherapy on grape cuttings that had passed the dormant period in order to determine the most effective mode of healing of grape cuttings from the GLRaV-3 virus. The data obtained by us in the course of this st

APA, Harvard, Vancouver, ISO, and other styles

37

Greiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.133.

Full text

Abstract:

Abstract This review addresses the clinical presentation, pathology, and therapy of several uncommon lymphoid proliferations. Because these lymphoproliferations span the characteristics of reactive polymorphous proliferations to clonal malignant neoplasms, they are often difficult to diagnose and treat effectively. In Section I, Dr. Greiner describes the pathology of the spectrum of atypical lymphoid disorders including Castleman's disease, angioimmunoblastic lymphadenopathy, lymphadenopathy in autoimmune diseases, posttransplant lymphoproliferative disorders, and X-linked lymphoproliferative

APA, Harvard, Vancouver, ISO, and other styles

38

Greiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.20000133.

Full text

Abstract:

This review addresses the clinical presentation, pathology, and therapy of several uncommon lymphoid proliferations. Because these lymphoproliferations span the characteristics of reactive polymorphous proliferations to clonal malignant neoplasms, they are often difficult to diagnose and treat effectively.In Section I, Dr. Greiner describes the pathology of the spectrum of atypical lymphoid disorders including Castleman's disease, angioimmunoblastic lymphadenopathy, lymphadenopathy in autoimmune diseases, posttransplant lymphoproliferative disorders, and X-linked lymphoproliferative disorder.

APA, Harvard, Vancouver, ISO, and other styles

39

Korzh, Elena V. "Interstitial lung diseases in persons infected with human immunodeficiency virus." PULMONOLOGIYA 33, no. 6 (2023): 841–48. http://dx.doi.org/10.18093/0869-0189-2023-33-6-841-848.

Full text

Abstract:

Diagnosis of interstitial lung diseases (ILD) in individuals infected with the human immunodeficiency virus (HIV) remains poorly understood.The purpose of the work was to demonstrate approaches to the diagnosis of ILD in HIV-infected patients with different levels of CD4 lymphocytes. An analysis of literature data and clinical observations of ILD in HIV-infected individuals (n = 2) whose CD4 lymphocyte count was 677 (37.5%) and 1 (0.21%) cells/μl are presented. The patients were observed and treated for a long time by pulmonology specialists, including anti-tuberculosis chemotherapy. The patie

APA, Harvard, Vancouver, ISO, and other styles

40

Polyakov, Yu Yu, E. A. Baryakh, E. N. Misyurina, et al. "Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2." Oncohematology 19, no. 2 (2024): 101–8. http://dx.doi.org/10.17650/1818-8346-2024-19-2-101-108.

Full text

Abstract:

Treatment of immunocompromised patients with novel coronavirus infection (COVID-19) presents significant challenges. Currently, there are no unified approaches to the treatment of persistent COVID-19 in hematological malignancies. There is a need to develop recommendations for the management of such patients, chemotherapy protocols, as well as therapy for COVID-19 in case of SARS-CoV-2 virus persistence. Doctors are faced with cases of virus persistence, clinical manifestations during a long course of the infectious process and are not provided with methodological recommendations for patient s

APA, Harvard, Vancouver, ISO, and other styles

41

Islas-Muñoz, B., B. Méndez-Sotelo, J. Reyes-Pérez, M. Jiménez-de los Santos, R. Herrera-Goepfert, and P. Volkow-Fernández. "Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C." International Journal of STD & AIDS 31, no. 11 (2020): 1110–13. http://dx.doi.org/10.1177/0956462420943027.

Full text

Abstract:

We present the case of a 28-year-old man with recently-diagnosed human immunodeficiency virus and hepatitis C virus infection. He developed obstructive cholangiopathy secondary to cytomegalovirus and Kaposi sarcoma, both diagnosed by endoscopic retrograde cholangiopancreatography and biopsies. He received antiretroviral therapy, chemotherapy and valganciclovir with full recovery.

APA, Harvard, Vancouver, ISO, and other styles

42

Uchiyama, Michihiro, Yotaro Tamai, and Takashi Ikeda. "Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma." International Journal of Infectious Diseases 14, no. 3 (2010): e265-e266. http://dx.doi.org/10.1016/j.ijid.2009.04.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Nowak, J. S., and D. Januszkiewicz. "CHEMOTHERAPY OF CHILDREN WITH LYMPHOPROLIFERATIVE DISEASES AS A RISK FACTOR FOR HEPATITIS C VIRUS INFECTION. 127." Pediatric Research 41, no. 5 (1997): 770. http://dx.doi.org/10.1203/00006450-199705000-00146.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ramphal, Raveena, Ronald M. Grant, Biljana Dzolganovski, et al. "Herpes Simplex Virus in Febrile Neutropenic Children Undergoing Chemotherapy for Cancer." Pediatric Infectious Disease Journal 26, no. 8 (2007): 700–704. http://dx.doi.org/10.1097/inf.0b013e31805cdc11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Pham, Hoang. "Mathematical Modeling the Time-Delay Interactions between Tumor Viruses and the Immune System with the Effects of Chemotherapy and Autoimmune Diseases." Mathematics 10, no. 5 (2022): 756. http://dx.doi.org/10.3390/math10050756.

Full text

Abstract:

The immune system is the body’s defense against pathogens, which are complex living organisms found in many parts in the body including organs, tissues, cells, molecules, and proteins. When the immune system works properly, it can recognize and kill the abnormal cells and the infected cells. Otherwise, it can attack the body’s healthy cells even if there is no invader. Many researchers have developed immunotherapy (or cancer vaccines) and have used chemotherapy for cancer treatment that can kill fast-growing cancer cells or at least slow down tumor growth. However, chemotherapy drugs travel th

APA, Harvard, Vancouver, ISO, and other styles

46

Nishida, Tsutomu, Naoki Hiramatsu, Masao Mizuki, et al. "Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic." Hepatology Research 43, no. 4 (2012): 339–46. http://dx.doi.org/10.1111/j.1872-034x.2012.01073.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Shahgolzari, Mehdi, Srividhya Venkataraman, Anne Osano, Paul Achile Akpa, and Kathleen Hefferon. "Plant Virus Nanoparticles Combat Cancer." Vaccines 11, no. 8 (2023): 1278. http://dx.doi.org/10.3390/vaccines11081278.

Full text

Abstract:

Plant virus nanoparticles (PVNPs) have garnered considerable interest as a promising nanotechnology approach to combat cancer. Owing to their biocompatibility, stability, and adjustable surface functionality, PVNPs hold tremendous potential for both therapeutic and imaging applications. The versatility of PVNPs is evident from their ability to be tailored to transport a range of therapeutic agents, including chemotherapy drugs, siRNA, and immunomodulators, thereby facilitating targeted delivery to the tumor microenvironment (TME). Furthermore, PVNPs may be customized with targeting ligands to

APA, Harvard, Vancouver, ISO, and other styles

48

Castelli, Roberto, Riccardo Schiavon, Carlo Preti, and Laurenzia Ferraris. "HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy." Cardiovascular & Hematological Disorders-Drug Targets 20, no. 3 (2020): 175–80. http://dx.doi.org/10.2174/1871529x20666200415121009.

Full text

Abstract:

HIV-positive patients have a 60- to 200-fold increased incidence of Non-Hodgkin Lymphomas (NHL) because of their impaired cellular immunity. Some NHL are considered Acquired Immunodeficiency Syndrome (AIDS) defining conditions. Diffuse large B-cell Lymphoma (DLBC) and Burkitt Lymphoma (BL) are the most commonly observed, whereas Primary Effusion Lymphoma (PEL), Central Nervous System Lymphomas (PCNSL), Plasmablastic Lymphoma (PBL) and classic Hodgkin Lymphoma (HL) are far less frequent. Multicentric Castleman disease (MCD) is an aggressive lymphoproliferative disorder highly prevalent in HIV-p

APA, Harvard, Vancouver, ISO, and other styles

49

Li, Shu, Xiao-Yu Liu, Qiu Pan, et al. "Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells." Viruses 11, no. 4 (2019): 378. http://dx.doi.org/10.3390/v11040378.

Full text

Abstract:

Hepatitis C virus (HCV) is a major cause of human chronic liver disease and hepatocellular carcinoma. Our recent studies showed that α1,6-fucosyltransferase (FUT8), a key glycosyltransferase, was the most up-regulated glycosyltransferase after the HCV infection of human hepatocellular carcinoma Huh7.5.1 cells. Here, we further studied the effects and possible mechanism of FUT8 on the proliferation of HCV and chemotherapy-resistance of HCV-infected Huh7.5.1 cells. The effects of FUT8 on the proliferation and drug resistance of HCV-infected Huh7.5.1 cells were analyzed by flow cytometry analysis

APA, Harvard, Vancouver, ISO, and other styles

50

Cesaro, Simone, Mareva Giacchino, Francesca Fioredda, et al. "Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients." BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/707691.

Full text

Abstract:

Objective.Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children.Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed.Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations wi

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!